XSVM - ETF AI Analysis
Top Page
Invesco S&P SmallCap Value with Momentum ETF (XSVM)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and in recent months, indicating positive momentum.
Leading Holdings Performing Well
Most of the top positions, such as StoneX Group, The Andersons, and Vishay Intertechnology, have delivered strong year-to-date gains that support the fund’s results.
Diversified Across Many Sectors
Holdings spread across financials, consumer cyclical, energy, technology, and several other sectors help reduce the impact of weakness in any single industry.
Negative Factors
Heavy Tilt Toward Financials
A large share of the portfolio is in financial stocks, which increases the fund’s sensitivity to problems in that sector.
High U.S. Concentration
With almost all assets invested in U.S. companies, the ETF offers little geographic diversification outside the United States.
Moderate Expense Ratio
The fund’s fees are not especially low for an ETF, which can slightly reduce long-term returns compared with cheaper options.
XSVM vs. SPDR S&P 500 ETF (SPY)
AUM614.65M
RegionNorth America
Expense Ratio0.37%
Beta0.86
IssuerInvesco
Inception DateMar 03, 2005
Dividend Yield1.85%
Asset ClassEquity
Index TrackedS&P SmallCap 600 High Momentum Value
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume23,907
30 Day Avg. Volume33,478
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
72.03Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering118
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XSVM Summary
XSVM is an ETF that follows the S&P SmallCap 600 High Momentum Value Index, focusing on smaller U.S. companies that look cheap based on fundamentals but have recently been doing well in the market. It holds a mix of sectors like financials, consumer companies, energy, and technology, with names such as StoneX Group and United Natural Foods among its top holdings. Someone might invest in XSVM to seek growth from lesser-known small companies and to diversify beyond large, well-known stocks. A key risk is that small-cap stocks can be very volatile and can go up and down more than the overall market.
How much will it cost me?The Invesco S&P SmallCap Value with Momentum ETF (XSVM) has an expense ratio of 0.37%, meaning you’ll pay $3.70 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it tracks a specialized index and uses a more active strategy to combine value and momentum investing. It’s designed for investors seeking targeted exposure to small-cap stocks with strong growth potential.
What would affect this ETF?XSVM’s focus on U.S. small-cap companies with strong value and momentum characteristics could benefit from economic growth and favorable consumer spending trends, especially in sectors like financials and consumer cyclical, which make up a significant portion of its holdings. However, the ETF may face challenges during periods of economic uncertainty or rising interest rates, which can negatively impact small-cap stocks and sectors like real estate and financials. Regulatory changes or shifts in market sentiment could also influence the performance of its top holdings.
XSVM Top 10 Holdings
XSVM is leaning hard into U.S. small-cap value names, with financials and consumer-focused stocks setting the tone. StoneX Group and The Andersons are among the steady climbers, giving the fund a solid backbone, while Vishay Intertechnology has been a real bright spot, adding some spark from the tech side. Par Pacific has also been rising, helping the energy sleeve pull its weight. On the flip side, MarineMax and United Natural Foods look more like repair projects than engines of growth, occasionally dragging on what is otherwise a momentum-driven small-cap story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| StoneX Group | 1.89% | $11.49M | $8.33B | 71.83% | 58 Neutral | |
| The Andersons | 1.87% | $11.35M | $2.70B | 114.76% | 71 Outperform | |
| United Natural Foods | 1.72% | $10.45M | $3.06B | 91.11% | 52 Neutral | |
| Par Pacific Holdings | 1.58% | $9.58M | $3.33B | 352.08% | 67 Neutral | |
| Marinemax | 1.54% | $9.35M | $609.30M | 26.01% | 51 Neutral | |
| Vishay Intertechnology | 1.46% | $8.85M | $4.16B | 123.63% | 55 Neutral | |
| AdaptHealth | 1.41% | $8.54M | $1.77B | 49.88% | 74 Outperform | |
| Sonic Automotive | 1.33% | $8.06M | $2.54B | 20.48% | 61 Neutral | |
| Deluxe | 1.29% | $7.84M | $1.41B | 105.81% | 72 Outperform | |
| Genworth Financial | 1.25% | $7.58M | $3.42B | 28.55% | 60 Neutral |
XSVM Technical Analysis
Positive
―
Price Trends
61.80
Positive
60.94
Positive
57.89
Positive
Market Momentum
1.26
Positive
61.04
Neutral
66.82
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XSVM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 64.55, equal to the 50-day MA of 61.80, and equal to the 200-day MA of 57.89, indicating a bullish trend. The MACD of 1.26 indicates Positive momentum. The RSI at 61.04 is Neutral, neither overbought nor oversold. The STOCH value of 66.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XSVM.
XSVM Peer Comparison
Comparison Results
Performance Comparison
XSVM
Invesco S&P SmallCap Value with Momentum ETF
66.13
18.34
38.38%
OSCV
Opus Small Cap Value ETF
―
―
―
ISCV
iShares Morningstar Small Cap Value ETF
―
―
―
RZV
Invesco S&P Smallcap 600 Pure Value ETF
―
―
―
SVAL
iShares US Small Cap Value Factor ETF
―
―
―
FYT
First Trust Small Cap Value AlphaDEX Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents